(Q40051440)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

title

Diagnostic challenges of kidney diseases in HIV-infected patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference

Elisabeth Botelho-Nevers

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Nicolas Maillard

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Amandine Gagneux-Brunon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

author name string

Robin Chazot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Anne Frésard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Christophe Mariat

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

Frédéric Lucht

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

publication date

22 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Anti-infective Therapy

29 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

page(s)

903-915

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

Future challenges for clinical care of an ageing population infected with HIV: a modelling study

29 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

HIV and kidney disease in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Deteriorating renal function and clinical outcomes in HIV-positive persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

The impact of HIV on chronic kidney disease outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

The kidney as a reservoir for HIV-1 after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Identification of HIV-1 genitourinary tract compartmentalization by analyzing the env gene sequences in urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

HIV-associated kidney glomerular diseases: changes with time and HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Predictors of HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

HIV-associated nephropathies: epidemiology, pathology, mechanisms and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

HIV-associated immune complex kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

HIV and kidney diseases: 35 years of history and consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Renal toxicity associated with tenofovir use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Pharmacogenetics of tenofovir treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat combination therapy for the treatment of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Tenofovir alafenamide vs. tenofovir disoproxil fumarate in single tablet regimens for initial HIV-1 therapy: a randomized phase 2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a r

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Renal AA-amyloidosis in intravenous drug users--a role for HIV-infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Extrahepatic comorbidities associated with hepatitis C virus in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

The risk of chronic kidney disease and mortality are increased after community-acquired acute kidney injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Renal transplantation in HIV-infected patients: 2010 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Cystatin C in HIV-infected patients: promising but not yet ready for prime time.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Urinary albumin excretion within the normal range is an independent risk for near-term development of kidney disease in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Low-grade proteinuria is highly prevalent in HIV-positive patients on antiretroviral treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Tubular and glomerular proteinuria in HIV-infected adults with estimated glomerular filtration rate ≥ 60 ml/min per 1.73 m2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Assessing kidney function--measured and estimated glomerular filtration rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Antiretrovirals and the kidney in current clinical practice: renal pharmacokinetics, alterations of renal function and renal toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Comparisons between validated estimated glomerular filtration rate equations and isotopic glomerular filtration rate in HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Are the creatinine-based equations accurate to estimate glomerular filtration rate in African American populations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Comparisons of creatinine and cystatin C for detection of kidney disease and prediction of all-cause mortality in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Comparison of cystatin C and creatinine to determine the incidence of composite adverse outcomes in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Use of glomerular filtration rate estimating equations for drug dosing in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

CKD-EPI equation: A suitable Glomerular Filtration Rate estimate for drug dosing in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Biomarkers of renal function, which and when?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Use of urine biomarker-derived clusters to predict the risk of chronic kidney disease and all-cause mortality in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Tenofovir use and urinary biomarkers among HIV-infected women in the Women's Interagency HIV Study (WIHS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Urinary markers of kidney injury and kidney function decline in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Association of urine α1-microglobulin with kidney function decline and mortality in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

HIV Infection, Tenofovir, and Urine α1-Microglobulin: A Cross-sectional Analysis in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Association of Kidney Function and Early Kidney Injury With Incident Hypertension in HIV-Infected Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Neutrophil gelatinase-associated lipocalin, a marker of tubular dysfunction, is not increased in long-term virologically controlled patients receiving a tenofovir/emtricitabine + nevirapine regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Preventing long-term tenofovir renal toxicity by pharmacokinetic assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Renal impairment in patients receiving a tenofovir-cART regimen: impact of tenofovir trough concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Randomized comparison of renal effects, efficacy, and safety with once-daily abacavir/lamivudine versus tenofovir/emtricitabine, administered with efavirenz, in antiretroviral-naive, HIV-1-infected adults: 48-week results from the ASSERT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, d

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor-Based Single-Tablet Regimen for Initial HIV-1 Therapy: A Randomized Phase 2 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Switching from efavirenz, emtricitabine, and tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b,

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Kidney Dysfunction and Markers of Inflammation in the Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Marker of Endothelial Dysfunction Asymmetric Dimethylarginine Is Elevated in HIV Infection but Not Associated With Subclinical Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Plasma fibroblast growth factor 23 and osteocalcin serum levels are associated with cardiovascular risk in HIV-1-infected patients receiving antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Correlates and Longitudinal Renal and Cardiovascular Implications of FGF23 Levels in HIV-Positive Individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

Pro: Prevention of acute kidney injury: time for teamwork and new biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2017.1379395

10.1080/14787210.2017.1379395

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28898114%20AND%20SRC:MED&resulttype=core&format=json

29 March 2020

1 reference